Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2025-02-14

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$969.1m reported value -25.7% vs Q3 2024
62positions
64.3%in top 10
14 new 14 added 29 reduced 17 sold out vs Q3 2024

Options: 0 call positions (— notional), 3 put positions ($157.4m notional) – listed below, not included above.

Holdings, Q4 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NATERA INC COM NTRA NTRA 876,766 $138.8m14.32% 14.32% AddedShares held: Q1 2024 1.8m, Q2 2024 1.2m, Q3 2024 870.2k, Q4 2024 876.8k +6.6k +6,573 0.8%
2 GSK PLC SPONSORED ADR GSK GSK 3,661,768 $123.8m12.78% 12.78% ReducedShares held: Q1 2024 3.8m, Q2 2024 3.5m, Q3 2024 4.1m, Q4 2024 3.7m -395.4k -395,438 -9.8%
3 VERA THERAPEUTICS INC CL A VERA VERA 1,600,015 $67.7m6.98% 6.98% ReducedShares held: Q1 2024 1.8m, Q2 2024 2.0m, Q3 2024 2.1m, Q4 2024 1.6m -450.1k -450,142 -22.0%
4 INSPIRE MED SYS INC COM INSP INSP 294,302 $54.6m5.63% 5.63% AddedShares held: Q1 2024 420.7k, Q2 2024 533.0k, Q3 2024 276.3k, Q4 2024 294.3k +18.0k +18,032 6.5%
5 HCA HEALTHCARE INC COM HCA HCA 175,808 $52.8m5.45% 5.45% AddedShares held: Q1 2024 103.8k, Q2 2024 135.5k, Q3 2024 129.1k, Q4 2024 175.8k +46.7k +46,724 36.2%
6 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 2,242,125 $49.4m5.10% 5.10% ReducedShares held: Q1 2024 6.0m, Q2 2024 4.7m, Q3 2024 3.2m, Q4 2024 2.2m -992.5k -992,513 -30.7%
7 REVVITY INC COM RVTY RVTY 392,518 $43.8m4.52% 4.52% ReducedShares held: Q1 2024 483.2k, Q2 2024 451.6k, Q3 2024 469.7k, Q4 2024 392.5k -77.2k -77,174 -16.4%
8 HEALTHEQUITY INC COM HQY HQY 386,697 $37.1m3.83% 3.83% AddedShares held: Q1 2024 421.3k, Q2 2024 413.5k, Q3 2024 319.1k, Q4 2024 386.7k +67.6k +67,619 21.2%
9 ZIMVIE INC COM ZIMV ZIMV 2,070,780 $28.9m2.98% 2.98% UnchangedShares held: Q1 2024 564.5k, Q2 2024 767.7k, Q3 2024 2.1m, Q4 2024 2.1m
10 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 678,787 $26.2m2.70% 2.70% AddedShares held: Q1 2024 411.5k, Q2 2024 505.8k, Q3 2024 445.2k, Q4 2024 678.8k +233.6k +233,583 52.5%
11 BIO-TECHNE CORP COM TECH TECH 299,310 $21.6m2.22% 2.22% ReducedShares held: Q1 2024 607.7k, Q2 2024 543.0k, Q3 2024 663.6k, Q4 2024 299.3k -364.3k -364,263 -54.9%
12 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 719,836 $18.2m1.88% 1.88% AddedShares held: Q1 2024 711.1k, Q2 2024 633.0k, Q3 2024 564.9k, Q4 2024 719.8k +154.9k +154,934 27.4%
13 VIATRIS INC COM VTRS VTRS 1,272,102 $15.8m1.63% 1.63% ReducedShares held: Q1 2024 1.3m, Q2 2024 1.3m, Q3 2024 1.7m, Q4 2024 1.3m -454.3k -454,252 -26.3%
14 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 43,703 $15.4m1.59% 1.59% ReducedShares held: Q1 2024 251.1k, Q2 2024 235.4k, Q3 2024 130.9k, Q4 2024 43.7k -87.2k -87,246 -66.6%
15 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 779,998 $15.0m1.54% 1.54% AddedShares held: Q1 2024 142.1k, Q2 2024 567.5k, Q3 2024 691.2k, Q4 2024 780.0k +88.8k +88,766 12.8%
16 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 1,980,312 $14.9m1.54% 1.54% AddedShares held: Q1 2024 1.4m, Q2 2024 1.2m, Q3 2024 535.4k, Q4 2024 2.0m +1.4m +1,444,907 269.9%
17 BRUKER CORP COM BRKR BRKR 234,934 $13.8m1.42% 1.42% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 234.9k
18 EDWARDS LIFESCIENCES CORP COM EW EW 170,678 $12.6m1.30% 1.30% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 170.7k
19 DEXCOM INC COM DXCM DXCM 148,688 $11.6m1.19% 1.19% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 148.7k
20 CENTENE CORP DEL COM CNC CNC 188,493 $11.4m1.18% 1.18% AddedShares held: Q1 2024 92.8k, Q2 2024 115.8k, Q3 2024 135.0k, Q4 2024 188.5k +53.5k +53,534 39.7%
21 TELEFLEX INCORPORATED COM TFX TFX 61,736 $11.0m1.13% 1.13% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 61.7k
22 ELEVANCE HEALTH INC COM ELV ELV 29,178 $10.8m1.11% 1.11% AddedShares held: Q1 2024 14.4k, Q2 2024 14.7k, Q3 2024 19.5k, Q4 2024 29.2k +9.7k +9,713 49.9%
23 VAXCYTE INC COM PCVX PCVX 127,588 $10.4m1.08% 1.08% NewShares held: Q1 2024 197.3k, Q2 2024 96.1k, Q3 2024 0, Q4 2024 127.6k
24 TRAVERE THERAPEUTICS INC COM TVTX TVTX 490,296 $8.5m0.88% 0.88% ReducedShares held: Q1 2024 955.6k, Q2 2024 1.1m, Q3 2024 869.9k, Q4 2024 490.3k -379.6k -379,617 -43.6%
25 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 2,827,000 $8.5m0.87% 0.87% ReducedShares held: Q1 2024 8.0m, Q2 2024 8.0m, Q3 2024 8.8m, Q4 2024 2.8m -5.9m -5,949,455 -67.8%
26 GUARDANT HEALTH INC COM GH GH 276,036 $8.4m0.87% 0.87% NewShares held: Q1 2024 449.6k, Q2 2024 99.4k, Q3 2024 0, Q4 2024 276.0k
27 REPLIGEN CORP COM RGEN RGEN 54,066 $7.8m0.80% 0.80% ReducedShares held: Q1 2024 8.2k, Q2 2024 194.3k, Q3 2024 163.6k, Q4 2024 54.1k -109.5k -109,527 -67.0%
28 IONIS PHARMACEUTICALS INC COM IONS IONS 214,952 $7.5m0.78% 0.78% ReducedShares held: Q1 2024 376.4k, Q2 2024 456.9k, Q3 2024 471.4k, Q4 2024 215.0k -256.4k -256,403 -54.4%
29 FORTREA HLDGS INC COMMON STOCK FTRE FTRE 401,733 $7.5m0.77% 0.77% ReducedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 458.0k, Q4 2024 401.7k -56.2k -56,234 -12.3%
30 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 275,362 $7.1m0.73% 0.73% ReducedShares held: Q1 2024 354.0k, Q2 2024 329.9k, Q3 2024 307.4k, Q4 2024 275.4k -32.0k -31,995 -10.4%
31 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 102,661 $6.7m0.69% 0.69% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 102.7k
32 LIQUIDIA CORPORATION COM NEW LQDA LQDA 571,305 $6.7m0.69% 0.69% AddedShares held: Q1 2024 396.2k, Q2 2024 373.6k, Q3 2024 137.9k, Q4 2024 571.3k +433.4k +433,356 314.1%
33 MEDPACE HLDGS INC COM MEDP MEDP 19,049 $6.3m0.65% 0.65% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 19.0k
34 XENON PHARMACEUTICALS INC COM XENE XENE 155,540 $6.1m0.63% 0.63% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 155.5k
35 MANNKIND CORP COM NEW MNKD MNKD 911,025 $5.9m0.60% 0.60% ReducedShares held: Q1 2024 2.4m, Q2 2024 2.3m, Q3 2024 2.0m, Q4 2024 911.0k -1.1m -1,081,479 -54.3%
36 HUMANA INC COM HUM HUM 22,682 $5.8m0.59% 0.59% ReducedShares held: Q1 2024 35.5k, Q2 2024 38.0k, Q3 2024 33.9k, Q4 2024 22.7k -11.2k -11,178 -33.0%
37 HENRY SCHEIN INC COM HSIC HSIC 80,303 $5.6m0.57% 0.57% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 80.3k
38 DANAHER CORPORATION COM DHR DHR 22,209 $5.1m0.53% 0.53% ReducedShares held: Q1 2024 40.9k, Q2 2024 40.9k, Q3 2024 38.4k, Q4 2024 22.2k -16.2k -16,220 -42.2%
39 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 343,400 $4.5m0.47% 0.47% ReducedShares held: Q1 2024 3.1m, Q2 2024 3.6m, Q3 2024 4.1m, Q4 2024 343.4k -3.8m -3,761,913 -91.6%
40 PATTERSON COS INC COM PDCO PDCO 146,051 $4.5m0.47% 0.47% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 146.1k
41 GOSSAMER BIO INC COM GOSS GOSS 4,978,458 $4.5m0.46% 0.46% UnchangedShares held: Q1 2024 6.0m, Q2 2024 5.5m, Q3 2024 5.0m, Q4 2024 5.0m
42 EVOLUS INC COM EOLS EOLS 383,045 $4.2m0.44% 0.44% ReducedShares held: Q1 2024 0, Q2 2024 574.5k, Q3 2024 453.1k, Q4 2024 383.0k -70.0k -70,016 -15.4%
43 ICON PLC SHS ICLR ICLR 19,252 $4.0m0.42% 0.42% AddedShares held: Q1 2024 15.3k, Q2 2024 12.6k, Q3 2024 13.7k, Q4 2024 19.3k +5.6k +5,584 40.9%
44 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 105,581 $3.8m0.39% 0.39% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 105.6k
45 AVANTOR INC COM AVTR AVTR 168,369 $3.5m0.37% 0.37% UnchangedShares held: Q1 2024 125.4k, Q2 2024 125.4k, Q3 2024 168.4k, Q4 2024 168.4k
46 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 996,102 $3.0m0.31% 0.31% ReducedShares held: Q1 2024 1.4m, Q2 2024 1.3m, Q3 2024 1.3m, Q4 2024 996.1k -297.2k -297,155 -23.0%
47 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 1,003,678 $3.0m0.30% 0.30% AddedShares held: Q1 2024 1.2m, Q2 2024 1.1m, Q3 2024 998.1k, Q4 2024 1.0m +5.6k +5,599 0.6%
48 MERUS N V COM MRUS MRUS 68,258 $2.9m0.30% 0.30% UnchangedShares held: Q1 2024 119.5k, Q2 2024 66.5k, Q3 2024 68.3k, Q4 2024 68.3k
49 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 777,890 $2.7m0.28% 0.28% UnchangedShares held: Q1 2024 0, Q2 2024 496.2k, Q3 2024 777.9k, Q4 2024 777.9k
50 ZAI LAB LTD ADR ZLAB ZLAB 102,930 $2.7m0.28% 0.28% ReducedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 135.2k, Q4 2024 102.9k -32.3k -32,289 -23.9%
51 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 191,158 $2.7m0.27% 0.27% ReducedShares held: Q1 2024 0, Q2 2024 837.8k, Q3 2024 693.3k, Q4 2024 191.2k -502.1k -502,105 -72.4%
52 DENTSPLY SIRONA INC COM XRAY XRAY 139,656 $2.7m0.27% 0.27% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 139.7k
53 XOMA ROYALTY CORPORATION COM NEW XOMA XOMA 95,417 $2.5m0.26% 0.26% AddedShares held: Q1 2024 97.1k, Q2 2024 91.9k, Q3 2024 94.3k, Q4 2024 95.4k +1.1k +1,128 1.2%
54 ITEOS THERAPEUTICS INC COM ITOS ITOS 220,196 $1.7m0.17% 0.17% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 220.2k
55 KARYOPHARM THERAPEUTICS INC COM COM 2,088,757 $1.4m0.15% 0.15% ReducedShares held: Q1 2024 5.0m, Q2 2024 5.0m, Q3 2024 5.5m, Q4 2024 2.1m -3.5m -3,459,123 -62.4%
56 ZENAS BIOPHARMA INC COM ZBIO ZBIO 172,103 $1.4m0.15% 0.15% ReducedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 190.5k, Q4 2024 172.1k -18.4k -18,428 -9.7%
57 SUTRO BIOPHARMA INC COM COM 694,408 $1.3m0.13% 0.13% ReducedShares held: Q1 2024 1.1m, Q2 2024 1.7m, Q3 2024 1.8m, Q4 2024 694.4k -1.1m -1,147,581 -62.3%
58 INFLARX NV COM IFRX IFRX 492,452 $1.2m0.13% 0.13% ReducedShares held: Q1 2024 1.3m, Q2 2024 1.6m, Q3 2024 1.6m, Q4 2024 492.5k -1.1m -1,129,335 -69.6%
59 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 1,516,592 $735.5k0.08% 0.08% ReducedShares held: Q1 2024 6.2m, Q2 2024 4.3m, Q3 2024 3.3m, Q4 2024 1.5m -1.8m -1,792,717 -54.2%
60 ABSCI CORPORATION COM ABSI ABSI 199,464 $522.6k0.05% 0.05% ReducedShares held: Q1 2024 0, Q2 2024 325.5k, Q3 2024 272.9k, Q4 2024 199.5k -73.4k -73,405 -26.9%
61 ALECTOR INC COM ALEC ALEC 200,095 $378.2k0.04% 0.04% ReducedShares held: Q1 2024 536.2k, Q2 2024 541.7k, Q3 2024 332.8k, Q4 2024 200.1k -132.7k -132,661 -39.9%
62 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 98,895 $232.4k0.02% 0.02% ReducedShares held: Q1 2024 0, Q2 2024 610.9k, Q3 2024 406.6k, Q4 2024 98.9k -307.7k -307,663 -75.7%

Sold out since Q3 2024

SecurityTickerShares held beforeValue then
INSMED INC INSM INSM 1,089,404 $79.5m1.1m shares
BAUSCH HEALTH COS INC BHC BHC 1,530,914 $12.5m1.5m shares
INTRA-CELLULAR THERAPIES INC ITCI ITCI 124,491 $9.1m124.5k shares
BIOHAVEN LTD BHVN BHVN 132,537 $6.6m132.5k shares
BROOKDALE SR LIVING INC BKD BKD 861,268 $5.8m861.3k shares
PARAGON 28 INC FNA FNA 749,213 $5.0m749.2k shares
KURA ONCOLOGY INC KURA KURA 192,398 $3.8m192.4k shares
MOLINA HEALTHCARE INC MOH MOH 10,588 $3.6m10.6k shares
STAAR SURGICAL CO STAA STAA 91,199 $3.4m91.2k shares
IQVIA HLDGS INC IQV IQV 13,138 $3.1m13.1k shares
MARAVAI LIFESCIENCES HLDGS I MRVI MRVI 336,966 $2.8m337.0k shares
TOURMALINE BIO INC TRML TRML 84,380 $2.2m84.4k shares
NEVRO CORP NVRO NVRO 313,780 $1.8m313.8k shares
AEROVATE THERAPEUTICS INC 485,141 $1.0m485.1k shares
STOKE THERAPEUTICS INC STOK STOK 52,006 $639.2k52.0k shares
AFFIMED N V AFMDQ AFMDQ 166,460 $559.3k166.5k shares
AC IMMUNE SA ACIU ACIU 99,313 $375.4k99.3k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 243,100 $124.3m243.1k shares Reduced
SPDR S&P 500 ETF TR SPY · Put SPYPut 29,800 $17.5m29.8k shares Reduced
ISHARES TR TLT · Put TLTPut 179,400 $15.7m179.4k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17